Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2024-01-19 Regulatory Filings
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the termination of a single sales and supply contract. It details the contract amount, the reason for termination (breach of contract by the counterparty), and the effective date. Since this is a specific regulatory disclosure regarding a material business event that does not fit into categories like M&A, financial reports, or shareholder communications, it falls under the general regulatory filing category.
2024-01-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in ownership, and purpose of holding (management influence) by a major shareholder (Choi Wan-gyu) of the company (Korea BNC). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-01-16 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure from a Korean company (한국비엔씨) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a material business event that does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2024-01-02 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to a previously disclosed contract amount due to the expiration of the contract period. Since this is a specific regulatory disclosure regarding a material business contract update that does not fit into categories like financial reports, dividends, or management changes, it is classified as a general regulatory filing.
2023-12-28 Korean
[기재정정]타법인주식및출자증권취득결정(자율공시)
M&A Activity Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous disclosure about the acquisition of shares in another company (타법인주식및출자증권취득결정). While it involves an acquisition, it is a formal regulatory disclosure filing rather than a standalone M&A announcement document or a press release. Given the specific nature of the filing as a regulatory update on a corporate action, it falls under the 'RNS' (Regulatory Filings) category as the most appropriate fallback for this type of structured exchange disclosure.
2023-12-21 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). The document explicitly states it is a correction to the 2022 Annual Report, detailing specific sections that were updated (e.g., company overview, capital usage, and management reports). Since it contains substantive financial data and is a formal amendment to the primary annual filing, it is classified as a 10-K. FY 2022
2023-12-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.